Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Crocetin imparts antiproliferative activity via inhibiting STAT3 signaling in hepatocellular carcinoma

Published:2021-09-23 Issue:11 Volume:73 Page:1348-1362
ISSN:1521-6543
Container-title:IUBMB Life
language:en
Short-container-title:IUBMB Life

Author:

Mohan Chakrabhavi Dhananjaya¹,Kim Chulwon²,Siveen Kodappully Sivaraman³,Manu Kanjoormana Aryan⁴,Rangappa Shobith⁵,Chinnathambi Arunachalam⁶,Alharbi Sulaiman Ali⁶,Rangappa Kanchugarakoppal S.⁷,Kumar Alan Prem⁸^ORCID,Ahn Kwang Seok²^ORCID

Affiliation:

1. Department of Studies in Molecular Biology University of Mysore Manasagangotri Mysore Karnataka India

2. Department of Science in Korean Medicine College of Korean Medicine, Kyung Hee University Seoul Republic of Korea

3. Flow Cytometry Core Facility Translational Research Institute, Academic Health System, Hamad Medical Corporation Doha Qatar

4. Department of Immunology Amala Cancer Research Center Thrissur Kerala India

5. Adichunchanagiri Institute for Molecular Medicine Adichunchanagiri University BG Nagara Nagamangala Taluk Karnataka India

6. Department of Botany and Microbiology College of Science, King Saud University Riyadh Saudi Arabia

7. Institution of Excellence, Vijnana Bhavan, University of Mysore Manasagangotri Mysore Karnataka India

8. Cancer Science Institute of Singapore and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore Singapore Singapore

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iub.2555

Reference75 articles.

1. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

2. Vitexin abrogates invasion and survival of hepatocellular carcinoma cells through targeting STAT3 signaling pathway

3. Epidemiology of Hepatocellular Carcinoma